Field Reimbursement Strategist, Respiratory Biologics

AstraZeneca plc; Wilmington (DE); On-site; USD 162,000 - 243,000; Full time

Job summary

AstraZeneca plc is seeking a Field Reimbursement Manager for Respiratory Biologics based in Sioux Falls, SD. The role focuses on minimizing reimbursement barriers, partnering with Market Access, Trade, and Clinical teams to provide compliant, customer-centered solutions.

The FRM will develop and execute reimbursement strategies, communicate payer criteria, and own a detailed Territory Plan while ensuring compliance with laws and AstraZeneca policies. Travel up to 50–75% is expected.

Qualifications

• Bachelor’s Degree required.
• 5+ years in healthcare/pharma/biotech.
• 2+ years in sales, managed care or reimbursement.
• Willingness to travel 50–75% (overnight).
• MBA or related graduate degree preferred.

Responsibilities

• Partner with Marketing, Sales and Managed Markets to review franchise plans and priorities.
• Identify trends, align resources, and communicate resolutions to customers.
• Maintain knowledge of Managed Care, benefit structures, and regulatory influences.
• Access and influence key decision makers.
• Maintain industry awareness and reimbursement guidelines.
• Analyze performance metrics and publish insights.
• Prepare provider-level communications.
• Develop and execute comprehensive Territory Plan.

Skills

Healthcare industry experience

Reimbursement experience

Market access knowledge

Territory planning

Communication skills

Education

Bachelor’s Degree

MBA or related graduate degree

Job description

AstraZeneca plc is seeking a Field Reimbursement Manager for Respiratory Biologics based in Sioux Falls, SD. The role focuses on minimizing reimbursement barriers, partnering with Market Access, Trade, and Clinical teams to provide compliant, customer-centered solutions.

The FRM will develop and execute reimbursement strategies, communicate payer criteria, and own a detailed Territory Plan while ensuring compliance with laws and AstraZeneca policies. Travel up to 50–75% is expected.